Furthermore, based on the mechanisms of action of HDAC inhibitors (HDACIs) in regulating acetylation modifications, we discuss the possibility that they could provide a new strategy for treating post-stroke epilepsy. The gene discussed is HDAC9; the disease is stroke disorder.